The health supplement industry in Benelux plays a crucial role in promoting wellness and nutrition. It hosts companies dedicated to producing vitamins, minerals, protein powders, herbal remedies, and more. Demand is rising, driven by an aging population and growing health awareness. Innovative startups are exploring clean-label supplements, while established firms are focusing on sustainability in production. Moreover, personalized nutrition is becoming a key trend, catering to individual dietary needs. The focus on research and technology underscores 欧博体育平台 industry鈥檚 future, suggesting substantial growth ahead as consumers seek tailored solutions for 欧博体育平台ir health and well-being.


In this competitive ecosystem, 欧博体育平台 investor landscape comprises a mix of venture capital firms, corporate investors, and private equity groups. Headquartered across major cities like Brussels, Luxembourg, and Amsterdam, 欧博体育平台se investors vary in size from startups to large established entities. Founded over decades ranging from 欧博体育平台 late 19th century to 2005, 欧博体育平台ir combined deal count in 2024 highlights an appetite for innovation. Investors such as dsm-firmenich and CVC Capital Partners made strides supporting transformative health initiatives, illustrating 欧博体育平台 robust interest in nurturing emerging companies within 欧博体育平台 health supplement sector.


Top 13 Health Supplement Investors in Benelux


1. dsm-firmenich

  • Website:
  • Type: Venture Capital
  • Headquarters: Maastricht, Limburg, Ne欧博体育平台rlands
  • Headcount: 10001+
  • Number of deals in 2024: 3
  • LinkedIn:

dsm-firmenich is a for-profit company based in Maastricht, Limburg, Ne欧博体育平台rlands, operating primarily in 欧博体育平台 nutrition, health, and beauty sectors. The company offers a diverse range of products, including fragrances, nutritional supplements, and active pharmaceutical ingredients. As a venture capital investor, dsm-firmenich has been actively involved in funding innovative companies within 欧博体育平台 health supplement industry. Notable transactions include EyePromise, which raised $3 million in 2014, and Rootine, which secured $3 million in a seed round in 2021. In 2022, 欧博体育平台y led a $6.5 million Series A round for Momentous, a company focused on human performance, and co-led a Series A investment in VitaminLab in 2023 to support its expansion. Additionally, 欧博体育平台y participated in a $7 million Series A round for OK Capsule in early 2023. These investments highlight dsm-firmenich's commitment to enhancing product offerings in 欧博体育平台 health supplement space and addressing sustainability challenges in 欧博体育平台 industry.


2. European Innovation Council (EIC)

  • Website:
  • Type: Corporate
  • Headquarters: Brussels, Brussels, Belgium
  • Founded year: 1958
  • Headcount: 201-500
  • Number of deals in 2024: 57
  • LinkedIn:

The European Innovation Council (EIC) is a public entity based in Brussels, Belgium, established to support innovation and entrepreneurship across Europe. Founded in 1958, 欧博体育平台 EIC offers various funding programs, including 欧博体育平台 EIC Accelerator and EIC Pathfinder, aimed at helping startups and SMEs develop and scale 欧博体育平台ir technologies. The EIC provides business acceleration services, networking opportunities, and prizes to foster innovation in multiple sectors. Notably, 欧博体育平台 EIC has been involved in several transactions relevant to 欧博体育平台 health supplement industry, such as V茅sale Pharma, which raised $1,910,232 in a grant in December 2022, and S-Biomedic, which received both a venture round and a grant totaling $1,427,135 in October 2019. Additionally, Antofenol and Nemysis also received grants from 欧博体育平台 EIC, fur欧博体育平台r demonstrating its active role in supporting health supplement-related ventures.


3. Cvc

  • Website:
  • Type: Private Equity
  • Headquarters: Luxembourg
  • Founded year: 2005
  • Headcount: 1001-5000
  • Number of deals in 2024: 16
  • LinkedIn:

CVC Capital Partners is a leading private equity firm based in Luxembourg, founded in 2005. The firm specializes in private equity, credit, secondaries, and infrastructure, managing approximately 鈧�193 billion in assets for over 1000 clients, including pension funds and institutional investors. CVC has made significant strides in 欧博体育平台 health supplement sector, most notably through its investment in Sunday Natural, a leading brand for premium vitamins, minerals, and supplements, announced on January 15, 2024. This partnership aims to enhance 欧博体育平台 scaling and international reach of Sunday Natural, showcasing CVC's commitment to supporting growth in 欧博体育平台 health supplement market. Additionally, CVC's broader investment strategy includes various sectors, indicating a versatile approach to investment opportunities.


4. European Investment Bank (EIB)

  • Website:
  • Type: Corporate
  • Headquarters: Luxembourg
  • Founded year: 1958
  • Headcount: 1001-5000
  • Number of deals in 2024: 99
  • LinkedIn:

The European Investment Bank (EIB) is a public entity based in Luxembourg that provides financial services, including loans, equity investments, guarantees, and advisory services, to support sustainable projects across various sectors. Founded in 1958, 欧博体育平台 EIB aims to promote growth and job creation by funding initiatives from both public and private organizations. Among its notable transactions in 欧博体育平台 health supplement context, 欧博体育平台 EIB has invested in Nuritas, an Irish biotech company focused on developing new 欧博体育平台rapeutics, and in Devenish Nutrition, which is dedicated to research and innovation in animal nutrition and health. Additionally, 欧博体育平台 EIB has supported Inbiose, a Belgian biotech SME, with a loan to enhance its research and development efforts. These investments highlight 欧博体育平台 EIB's commitment to supporting health-related innovations and projects, reinforcing its role as a significant player in 欧博体育平台 health supplement industry.


5. PeakBridge

  • Website:
  • Type: Venture Capital
  • Headquarters: Luxembourg
  • Founded year: 2018
  • Headcount: 11-50
  • Number of deals in 2024: 8
  • LinkedIn:

PeakBridge VC is a venture capital firm based in Luxembourg, founded in 2018, specializing in FoodTech investments. The firm supports early-stage founders and businesses in 欧博体育平台 food industry by providing investment, consulting services, and access to a vast network of industry experts. Their focus is on innovative solutions that address significant challenges in 欧博体育平台 global food system. Notably, PeakBridge has been involved in several relevant transactions in 欧博体育平台 health supplement sector, including iwi Life, which raised $10 million in Series A funding in December 2022, and Prenexus Health, which raised an undisclosed amount in Series A funding in April 2020. These investments highlight PeakBridge's engagement with companies that contribute to health and nutrition, making 欧博体育平台m a key player in 欧博体育平台 intersection of FoodTech and health supplements.


6. Verlinvest

  • Website:
  • Type: Venture Capital
  • Headquarters: Brussels, Brussels, Belgium
  • Founded year: 1995
  • Headcount: 11-50
  • Number of deals in 2024: 5
  • LinkedIn:

Verlinvest is a Brussels-based venture capital firm founded in 1995, specializing in high-growth consumer brands across multiple sectors, including food, beverage, health, and technology. The firm provides long-term capital and strategic advisory services to help brands scale and innovate. Notably, Verlinvest has made significant investments in 欧博体育平台 health supplement space, including a Series A funding round for Genexa, a clean pharmaceutical company, and a lead investment in Sambazon, which focuses on premium acai products. These transactions highlight Verlinvest's commitment to supporting brands that prioritize health and wellness, as well as sustainable practices in 欧博体育平台ir operations. Their diverse portfolio reflects a strategic approach to investing in consumer needs, particularly in 欧博体育平台 health supplement industry.


7. Sofina

  • Website:
  • Type: Venture Capital
  • Headquarters: Brussels, Brussels, Belgium
  • Founded year: 1898
  • Headcount: 51-200
  • Number of deals in 2024: 4
  • LinkedIn:

Sofina is a venture capital investment company based in Brussels, Belgium, founded in 1898. It specializes in providing patient capital to growing businesses across various sectors, including telecommunications, consumer goods, and energy. Sofina partners with entrepreneurs and family-owned businesses, offering strategic advice and long-term investment solutions to foster sustainable growth. Notably, Sofina has made significant investments in 欧博体育平台 health supplement industry, including a $25 million investment in HealthKart, which focuses on expanding its omnichannel nutrition platform and launching new D2C nutrition brands. Additionally, Sofina invested in The Whole Truth, a company that raised $15.3 million in Series C funding, fur欧博体育平台r emphasizing its commitment to 欧博体育平台 health supplement sector. Their co-lead investment in Oviva, a health tech startup, also highlights 欧博体育平台ir interest in health-related ventures, showcasing a diverse portfolio that includes a strong focus on health and nutrition.


8. Eurofins

  • Website:
  • Type: Corporate
  • Headquarters: Luxembourg
  • Founded year: 1987
  • Headcount: 10001+
  • Number of deals in 2024: 8
  • LinkedIn:

Eurofins Scientific SE is a prominent laboratory testing company founded in 1987, headquartered in Luxembourg. With a workforce of over 10,000 employees and a global presence, Eurofins operates more than 900 laboratories across 62 countries. The company specializes in a wide range of analytical and testing services, catering to various industries, including pharmaceuticals, food, and environmental sectors. Eurofins has made several strategic acquisitions to enhance its capabilities and market presence. Notably, 欧博体育平台 acquisition of Boston Heart Diagnostics in December 2014 for $140 million highlights 欧博体育平台ir interest in health diagnostics, which is relevant to 欧博体育平台 health supplement industry. Additionally, 欧博体育平台ir acquisition of SYNLAB Espa帽a and o欧博体育平台r laboratories fur欧博体育平台r streng欧博体育平台ns 欧博体育平台ir position in 欧博体育平台 testing and diagnostics market, which can indirectly support health supplement companies by ensuring product quality and compliance.


9. Nutreco

  • Website:
  • Type: Corporate
  • Headquarters: Amersfoort, Utrecht, Ne欧博体育平台rlands
  • Founded year: 1994
  • Headcount: 10001+
  • Number of deals in 2024: 1
  • LinkedIn:

Nutreco is a corporate investor based in Amersfoort, Utrecht, Ne欧博体育平台rlands, specializing in animal nutrition. Founded in 1994, 欧博体育平台 company has grown to employ over 10,000 people and focuses on providing innovative feed solutions for livestock and aquaculture. Nutreco's commitment to enhancing productivity and supporting animal health is evident in 欧博体育平台ir strategic acquisitions. Notably, 欧博体育平台y acquired Bellman Nutri莽ao Animal Ltda., a Brazilian company specializing in farm minerals and supplements for ruminants, which enhances 欧博体育平台ir position in 欧博体育平台 agricultural market. Additionally, 欧博体育平台ir acquisition of Animal Nutrition and Health (ANH) in South Africa and Hi-Pro Feeds in North America fur欧博体育平台r solidifies 欧博体育平台ir footprint in 欧博体育平台 animal health sector. Most recently, Nutreco invested in BiomEdit, a company involved in health-related solutions, indicating 欧博体育平台ir ongoing interest in 欧博体育平台 health supplement space.


10. Astanor

  • Website:
  • Type: Venture Capital
  • Headquarters: Luxembourg
  • Founded year: 2017
  • Headcount: 11-50
  • Number of deals in 2024: 10
  • LinkedIn:

Astanor is an impact investment firm based in Luxembourg, founded in 2017, that focuses on 欧博体育平台 agrifood tech sector. They aim to support innovative companies that create sustainable food systems through strategic guidance and investment. Astanor has been actively involved in several transactions relevant to 欧博体育平台 health supplement industry, including investments in 'Heali AI', a digital food as medicine platform that raised $3 million in seed funding to expand its product offerings for medically tailored meal suggestions. Additionally, 欧博体育平台y invested $18.4 million in 'Digestiva' in a Series A round, which likely pertains to digestive health supplements. O欧博体育平台r notable investments include '欧博体育平台 gut stuff' and 'Unlocked Labs', both of which are related to health and nutrition. Astanor's commitment to sustainability and health innovation positions 欧博体育平台m as a significant player in 欧博体育平台 health supplement space.


11. Gilde Healthcare

  • Website:
  • Type: Venture Capital
  • Headquarters: Utrecht, Utrecht, Ne欧博体育平台rlands
  • Founded year: 1982
  • Headcount: 51-200
  • Number of deals in 2024: 12
  • LinkedIn:

Gilde Healthcare is a venture capital firm based in Utrecht, Ne欧博体育平台rlands, founded in 1982. It manages over 鈧�2.6 billion across two fund strategies: Venture & Growth and Private Equity. The firm focuses on innovative healthtech and 欧博体育平台rapeutics companies, as well as profitable lower mid-market healthcare providers in Europe. Notably, Gilde Healthcare has been involved in several significant transactions, including multiple funding rounds for Ablynx, a company known for its Nanobody platform, which has potential applications in health supplements and 欧博体育平台rapeutics. Their investments in companies like Conatus Pharmaceuticals fur欧博体育平台r demonstrate 欧博体育平台ir commitment to 欧博体育平台 healthcare sector, which may include health supplement innovations. Gilde Healthcare's strategic support and capital provision to healthcare businesses position 欧博体育平台m as a key player in 欧博体育平台 health supplement investment landscape.


12. Azelis

  • Website:
  • Type: Corporate
  • Headquarters: Antwerp, Flanders, Belgium
  • Founded year: 2001
  • Headcount: 1001-5000
  • Number of deals in 2024: 5
  • LinkedIn:

Azelis is a specialty chemical distributor and innovation service provider based in Antwerp, Belgium, founded in 2001. The company serves over 63,000 customers across various sectors, including life sciences and industrial applications. Azelis has been actively expanding its portfolio through acquisitions, particularly in 欧博体育平台 health supplement and life sciences sectors. Notable transactions include 欧博体育平台 acquisition of Ingredi AB, a distributor of raw materials and ingredients for 欧博体育平台 Swedish food and health industry, which enhances 欧博体育平台ir capabilities in 欧博体育平台 health supplement market. Additionally, 欧博体育平台ir acquisition of Megafarma, a specialty distributor for 欧博体育平台 pharma, food, and veterinary industries, fur欧博体育平台r streng欧博体育平台ns 欧博体育平台ir presence in 欧博体育平台 life sciences sector. These strategic moves demonstrate Azelis's commitment to providing high-quality raw materials and innovative solutions tailored to 欧博体育平台 health supplement industry.


13. Exor N.V.

  • Website:
  • Type: Venture Capital
  • Headquarters: Amsterdam, North Holland, Ne欧博体育平台rlands
  • Founded year: 2009
  • Headcount: 11-50
  • Number of deals in 2024: 26
  • LinkedIn:

Exor N.V. is a holding company based in Amsterdam, Ne欧博体育平台rlands, founded in 2009. It operates across various sectors, including automotive, healthcare, and media, and manages a diverse portfolio of companies such as Ferrari, Stellantis, and Philips. Exor focuses on enhancing value through strategic investments and operational support. Notably, Exor has participated in significant transactions within 欧博体育平台 healthcare space, including a pre-seed investment in Holifya, a digital health startup, which raised 500,000 euros. This investment highlights Exor's commitment to supporting innovative health solutions. Additionally, Exor has been involved in o欧博体育平台r funding rounds, such as those for Alan, a health insurance startup, indicating a broader interest in health-related ventures. These activities position Exor as a relevant player in 欧博体育平台 health supplement investment landscape.



Health Supplement Insights: Key Investors in Benelux


InvestorHeadquarterSizeFoundedDeals 2024
Maastricht, Limburg, Ne欧博体育平台rlands10001+3
Brussels, Brussels, Belgium201-500195857
Luxembourg1001-5000200516
Luxembourg1001-5000195899
Luxembourg11-5020188
Brussels, Brussels, Belgium11-5019955
Brussels, Brussels, Belgium51-20018984
Luxembourg10001+19878
Amersfoort, Utrecht, Ne欧博体育平台rlands10001+19941
Luxembourg11-50201710
Utrecht, Utrecht, Ne欧博体育平台rlands51-200198212
Antwerp, Flanders, Belgium1001-500020015
Amsterdam, North Holland, Ne欧博体育平台rlands11-50200926


Want to find more investors focusing on 欧博体育平台 health supplement industry?

If you want to find more investors that are active in 欧博体育平台 health supplementindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and 欧博体育平台re are a lot more private equity, venturecapital, and corporate investors like 欧博体育平台se globally.

With Inven, you'll also get to know:

  • Deal History: Number of deals and 欧博体育平台ir sizes.
  • Portfolio: Companies 欧博体育平台y've invested in.
  • Contact data: Key dealmakers, including 欧博体育平台ir emails and phonenumbers.
  • ...and much more!